Alzheimer’s disease is the primary cause of age-related dementia. About 15 million people are affected by this neurodegenerative disease worldwide. It has so far not been possible to combat the causes of Alzheimer’s disease. Israeli researchers have now developed a novel approach for treatment. As they report in the journal Angewandte Chemie, the new drug, a molecule made from two nonphysiological amino acids, improves the cognitive abilities of mice with Alzheimer’s and reduces the amyloid plaques in their brains.
Many years before clinical symptoms appear, threadlike deposits of incorrectly folded amyloid â-peptides, known as plaques, form in the brains of Alzheimer’s patients. It was previously assumed that these plaques initiate the degeneration of nerve cells; however, more recent discoveries indicate that smaller, soluble aggregates of the amyloid-forming peptide are the actual cause for the loss of learning and memory functions. These oligomers of about twelve peptide units have a strong toxic effect on nerve cells. The new therapeutic approach taken by researchers working with Ehud Gazit at the University of Tel Aviv aims to block the formation of these toxic oligomers.
A drug molecule was rationally designed that contains an aromatic amino acid and a â-sheet breaker. Aromatic side-groups play a key role in the aggregation of amyloid-forming peptides; the drug should thus bind to the aromatic core of the â-amyloid peptide through its aromatic element. Also, in amyloid aggregates, the proteins adopt the form of â-sheets that are folded like accordions; the drug should thus be a â-breaker, a molecule that prevents proteins from folding into â-sheets. In addition, the molecule must be small so that it can be absorbed by the digestive tract after oral ingestion. It must also not be rapidly degraded by the body and must be nontoxic.
The small dipeptide—a molecule made of two amino acids—developed by Gazit’s team meets all of these requirements: the nonphysiological amino acid á-aminoisobutyric acid acts as a â-breaker, and the second amino acid, D-tryptophan, contains an indole group, which is an effective binder of aromatics. At the same time, D-tryptophan stabilizes the dipeptide, because D-amino acids are broken down more slowly in the body than are the physiological L-amino acids.
When genetically altered mice with Alzheimer’s disease are treated with the dipeptide, their disrupted cognitive functions normalize. A significant decrease in the concentration of amyloid-forming â-peptides and in the size of the plaques was found in the brains of these mice.
Author: Ehud Gazit, Tel Aviv University (Israel), http://www.tau.ac.il/lifesci/departments/biotech/members/gazit/gazit.html
Title: Cognitive-Performance Recovery of Alzheimer's Disease Model Mice by Modulation of Early Soluble Amyloidal Assemblies
Angewandte Chemie International Edition, doi: 10.1002/anie.200802123
Ehud Gazit | Angewandte Chemie
Scientists uncover the role of a protein in production & survival of myelin-forming cells
19.07.2018 | Advanced Science Research Center, GC/CUNY
NYSCF researchers develop novel bioengineering technique for personalized bone grafts
18.07.2018 | New York Stem Cell Foundation
A new manufacturing technique uses a process similar to newspaper printing to form smoother and more flexible metals for making ultrafast electronic devices.
The low-cost process, developed by Purdue University researchers, combines tools already used in industry for manufacturing metals on a large scale, but uses...
For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.
To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...
For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.
Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...
Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.
A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...
Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.
"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....
13.07.2018 | Event News
12.07.2018 | Event News
03.07.2018 | Event News
20.07.2018 | Power and Electrical Engineering
20.07.2018 | Information Technology
20.07.2018 | Materials Sciences